BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21636217)

  • 1. Concerns about dextromethorphan as a potential rapid-acting antidepressant.
    Zhou Z; Wu J; Yang C
    Med Hypotheses; 2011 Aug; 77(2):309-10. PubMed ID: 21636217
    [No Abstract]   [Full Text] [Related]  

  • 2. Dextromethorphan as a potential rapid-acting antidepressant.
    Lauterbach EC
    Med Hypotheses; 2011 May; 76(5):717-9. PubMed ID: 21367535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
    Nguyen L; Matsumoto RR
    Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Resistant Depression with Loss of Antidepressant Response: Rapid-Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging Molecule.
    Lauterbach EC
    Psychopharmacol Bull; 2016 Aug; 46(2):53-58. PubMed ID: 27738380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials.
    Majeed A; Xiong J; Teopiz KM; Ng J; Ho R; Rosenblat JD; Phan L; Cao B; McIntyre RS
    Expert Opin Emerg Drugs; 2021 Mar; 26(1):63-74. PubMed ID: 33682569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NMDA receptor and nitric oxide/cyclic guanosine monophosphate pathway in the antidepressant-like effect of dextromethorphan in mice forced swimming test and tail suspension test.
    Sakhaee E; Ostadhadi S; Khan MI; Yousefi F; Norouzi-Javidan A; Akbarian R; Chamanara M; Zolfaghari S; Dehpour AR
    Biomed Pharmacother; 2017 Jan; 85():627-634. PubMed ID: 27908707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of antidepressant-like effects of dextromethorphan on differential reinforcement of low-rate 72-s performance in rats.
    Lynch CJ; Prus AJ
    Behav Pharmacol; 2021 Oct; 32(7):549-560. PubMed ID: 34417357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esmethadone-HCl (REL-1017): a promising rapid antidepressant.
    Fava M; Stahl SM; De Martin S; Mattarei A; Bettini E; Comai S; Alimonti A; Bifari F; Pani L; Folli F; Guidetti C; Furlan A; Sgrignani J; Locatelli P; Cavalli A; O'Gorman C; Traversa S; Inturrisi CE; Pappagallo M; Manfredi PL
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1463-1476. PubMed ID: 36890259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextromethorphan: From Cough Suppressant to Antidepressant.
    Kverno K
    J Psychosoc Nurs Ment Health Serv; 2022 Nov; 60(11):9-11. PubMed ID: 36317836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does ketamine elicit a rapid antidepressant response?
    Kavalali ET; Monteggia LM
    Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting glutamate signalling in depression: progress and prospects.
    Murrough JW; Abdallah CG; Mathew SJ
    Nat Rev Drug Discov; 2017 Jul; 16(7):472-486. PubMed ID: 28303025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What ketamine can teach us about the opioid system in depression?
    Perez-Caballero L; Perez V; Berrocoso E
    Expert Opin Drug Discov; 2020 Dec; 15(12):1369-1372. PubMed ID: 32568562
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives on glutamate receptor antagonists as antidepressants.
    Chung C
    Arch Pharm Res; 2012 Mar; 35(4):573-7. PubMed ID: 22553049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextromethorphan/Bupropion: First Approval.
    Keam SJ
    CNS Drugs; 2022 Nov; 36(11):1229-1238. PubMed ID: 36301443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of dextromethorphan/quinidine:comparison with ketamine.
    Stahl SM
    CNS Spectr; 2013 Oct; 18(5):225-7. PubMed ID: 24050154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine for Treatment-Resistant Depression: a New Advocate.
    Pérez-Esparza R
    Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice.
    Nguyen L; Scandinaro AL; Matsumoto RR
    Pharmacol Biochem Behav; 2017 Oct; 161():30-37. PubMed ID: 28916283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-based antidepressants: 20 years on.
    Skolnick P; Popik P; Trullas R
    Trends Pharmacol Sci; 2009 Nov; 30(11):563-9. PubMed ID: 19837463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.